BLUE ASH, Ohio--(BUSINESS WIRE)-- #CCO--Resilience, a technology-forward contract development and manufacturing organization (CDMO) dedicated to broadening access to complex medicines, today announced that in line with its more focused operating model, the company has divested a non‐core asset to further streamline operations and strengthen long‐term value creation. The company’s cell therapy manufacturing facility in East Norriton, Pennsylvania was acquired by Made Scientific, Inc. “Over the past yea
Resilience Further Advances North American Manufacturing Strategy Transformation
